FDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drug

Posted by on May 19, 2020 2:33 pm
Categories: US National Stories

The FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of “serious heart rhythm problems.”

Leave a Reply

Your email address will not be published. Required fields are marked *